AXA S.A., FR0000120628

UBS raises target for AXA stock from EUR 51 to EUR 55

Published on 10/20/2026 at 09:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Underlying earnings per share rose 8.00 percent in half-year 2026. AXA stock costs EUR 42.55 on October 20, 2026 versus EUR 42.40.

Shareholder return and earnings

AXA agreed to a EUR 470.80 million buyback on October 1, 2026.
Underlying earnings per share grew 8.00 percent in the first half of 2026.
AXA stock trades at EUR 42.55 at 9:35 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.35 percent above the Xetra close of October 19, 2026.

Aquarellgemälde einer Krankenhausstation, Pflegerin legt einem Patienten eine Sauerstoffmaske an, hellblaue und weiße Farbtöne, wandmontierte Gasanschlüsse erkennbar — Air Liquide FR0000120628 versorgt Krankenhäuser weltweit mit medizinischem Sauerstoff für Patienten täglich, Illustration mit AI erstellt.

AXA (FR0000120628) became the subject of a UBS target increase from EUR 51.00 to EUR 55.00 on October 14, 2026, according to Ideal Investisseur. AXA stock was trading at EUR 42.55 at Lang & Schwarz on October 20, 2026 at 9:35 a.m. CEST, plus 0.35 percent versus the Xetra close of October 19, 2026 at EUR 42.40. The target change gives investors a fresh valuation reference while the share remains below the new UBS level.

Why UBS lifted the target

UBS kept its buy rating while raising the AXA target from EUR 51.00 to EUR 55.00, the October 14, 2026 analyst update said. At the Lang & Schwarz price of EUR 42.55, the new target lies 29.26 percent above the price. The comparison points to a wider valuation gap than the previous target implied.

Operating figures support the case

AXA's first-half 2026 results showed underlying earnings per share growth of 8.00 percent, placing performance at the upper end of the company's 6.00 percent to 8.00 percent target range, according to Yahoo Finance. Management also reported a Solvency II ratio of 218.00 percent and a 90.10 percent property and casualty combined ratio for the half year. The ratio comparison matters because AXA is balancing capital strength with underwriting performance.

Three dates frame the stock

AXA's recent chronology runs from first-half 2026 earnings on July 31, 2026, when underlying earnings per share grew 8.00 percent, to the October 1, 2026 agreement for a EUR 470.80 million share buyback, and then to the October 14, 2026 UBS target increase. The earnings-call figures were published by Yahoo Finance, while the buyback was announced by AXA.

The next scheduled sales and revenue release is October 28, 2026, according to MarketScreener. The buyback agreement can continue through October 29, 2026, under the AXA release.

AXA stock stays below target

The current valuation reference is therefore split between a EUR 55.00 UBS target and the EUR 42.55 Lang & Schwarz quote. The upcoming October sales update may provide the next operating checkpoint for the insurer.

AXA stock was trading at EUR 42.55 at Lang & Schwarz on October 20, 2026 at 9:35 a.m. CEST, plus 0.35 percent versus the Xetra close of October 19, 2026 at EUR 42.40. The further course of trading is shown by the continuously updated real-time quote of AXA stock.